Home › Vivus: Qsymia Sales Dip - Is A Lower Price Needed?
 

Keywords :   


Vivus: Qsymia Sales Dip - Is A Lower Price Needed?

2015-02-08 09:08:40| Biotech - Topix.net

Vivus investors have seen Qsymia scripts remain in a pretty tight channel for over 15 months. While the sales have remained fairly steady, the arrival of a new competitor could have shifted the market in such a way that Vivus will have little choice but to respond.

Tags: price sales needed lower

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
More »